CEP-33457

· Cephalon, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CEP-33457, covering 2022-12-16 to 2022-12-30. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus [Phase 3]

See pricing